Ian MacGregor

2.8k total citations
88 papers, 2.2k citations indexed

About

Ian MacGregor is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian MacGregor has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Hematology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian MacGregor's work include Prion Diseases and Protein Misfolding (26 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Protease and Inhibitor Mechanisms (13 papers). Ian MacGregor is often cited by papers focused on Prion Diseases and Protein Misfolding (26 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Protease and Inhibitor Mechanisms (13 papers). Ian MacGregor collaborates with scholars based in United Kingdom, United States and France. Ian MacGregor's co-authors include C V Prowse, N. A. Booth, O. Drummond, Bruce Bennett, J. Dawes, Andrew J.G. Simpson, A Croll, V. Hornsey, David A. Lane and Duncan S. Pepper and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Ian MacGregor

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian MacGregor United Kingdom 26 781 712 431 366 260 88 2.2k
Shosuke Okamoto Japan 22 697 0.9× 592 0.8× 183 0.4× 295 0.8× 390 1.5× 81 2.4k
Hansjörg Schwertz United States 26 1.2k 1.6× 909 1.3× 317 0.7× 342 0.9× 328 1.3× 50 2.8k
N. A. Booth United Kingdom 27 1.1k 1.4× 426 0.6× 544 1.3× 654 1.8× 162 0.6× 64 2.1k
Roberto Lorenzet Italy 24 860 1.1× 414 0.6× 213 0.5× 196 0.5× 307 1.2× 41 2.4k
P. Friberger Sweden 18 606 0.8× 286 0.4× 383 0.9× 309 0.8× 189 0.7× 42 1.6k
Gerhard Dickneite Germany 32 1.2k 1.5× 397 0.6× 477 1.1× 80 0.2× 442 1.7× 111 3.1k
Naomi L. Esmon United States 27 1.9k 2.4× 919 1.3× 412 1.0× 266 0.7× 286 1.1× 45 4.5k
H. L. Nossel United States 29 1.8k 2.4× 388 0.5× 1.4k 3.2× 296 0.8× 335 1.3× 71 3.5k
Concetta T. Ammollo Italy 17 671 0.9× 726 1.0× 445 1.0× 190 0.5× 252 1.0× 27 3.1k
Trevor W. Barrowcliffe United Kingdom 26 1.1k 1.4× 258 0.4× 242 0.6× 166 0.5× 460 1.8× 105 2.1k

Countries citing papers authored by Ian MacGregor

Since Specialization
Citations

This map shows the geographic impact of Ian MacGregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian MacGregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian MacGregor more than expected).

Fields of papers citing papers by Ian MacGregor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian MacGregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian MacGregor. The network helps show where Ian MacGregor may publish in the future.

Co-authorship network of co-authors of Ian MacGregor

This figure shows the co-authorship network connecting the top 25 collaborators of Ian MacGregor. A scholar is included among the top collaborators of Ian MacGregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian MacGregor. Ian MacGregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peden, Alexander, M. G. K. Jones, Helen Yull, et al.. (2008). Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrPSc) associated with variant Creutzfeldt-Jakob disease. Prion.
2.
Hornsey, V., O. Drummond, L. McMillan, et al.. (2008). Cold storage of pooled, buffy‐coat‐derived, leucoreduced platelets in plasma. Vox Sanguinis. 95(1). 26–32. 27 indexed citations
3.
Foster, Peter R., B. Griffin, Carol Bienek, et al.. (2004). Distribution of a bovine spongiform encephalopathy‐derived agent over ion‐exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sanguinis. 86(2). 92–99. 25 indexed citations
4.
MacGregor, Ian & O. Drummond. (2001). Species differences in the blood content of the normal cellular isoform of prion protein, PrPc, measured by time‐resolved fluoroimmunoassay. Vox Sanguinis. 81(4). 236–240. 17 indexed citations
5.
Krailadsiri, Pranee, Rachel J. Perry, O. Drummond, et al.. (2001). The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components. Transfusion and Apheresis Science. 25(3). 177–178. 3 indexed citations
6.
MacGregor, Ian. (2001). Prion protein and developments in its detection. Transfusion Medicine. 11(1). 3–14. 35 indexed citations
7.
MacGregor, Ian, et al.. (2000). Distribution of normal prion protein in blood. Transfusion Science. 22(1-2). 51–51. 8 indexed citations
8.
Prowse, C V & Ian MacGregor. (1998). Neoantigens and antibodies to factor VIII. Blood Reviews. 12(2). 99–105. 7 indexed citations
9.
MacGregor, Ian, et al.. (1997). Modulation of Human Endothelial Thrombomodulin by Neutrophils and Their Release Products. American Journal of Respiratory and Critical Care Medicine. 155(1). 47–52. 52 indexed citations
10.
Donnelly, Seamas C., Ian MacGregor, Alireza Zamani, et al.. (1995). Plasma Elastase Levels and the Development of the Adult Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 151(5). 1428–1433. 124 indexed citations
11.
MacGregor, Ian, et al.. (1995). In vivo Models of Thrombogenic Potential: Usefulness and Limitations. Acta Haematologica. 94(1). 18–24. 7 indexed citations
12.
MacGregor, Ian, et al.. (1993). Definition of epitopes within plasminogen activator inhibitor type-1 (PAI-1) using multiple peptide synthesis. Fibrinolysis and Proteolysis. 7(4). 257–263. 8 indexed citations
13.
Wieczorek, Iwona, Ian MacGregor, R.J. Prescott, & C A Ludlam. (1992). The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera. Blood Coagulation & Fibrinolysis. 3(6). 823–826. 16 indexed citations
14.
Brown, Gillian, Ellen Drost, Ken Donaldson, Ian MacGregor, & William MacNee. (1991). Reduction of the Proteolytic Activity of Neutrophils by Exposure to Cigarette Smoke in Vitro. Experimental Lung Research. 17(5). 923–937. 7 indexed citations
15.
MacDonald, Shirley L., et al.. (1991). Hypotensive effects of stroma‐free haemoglobin solutions attributable to adenine nucleotides. Transfusion Medicine. 1(1). 17–23. 2 indexed citations
16.
MacGregor, Ian, et al.. (1990). Thrombogenicity of a factor IX concentrate quantitated in a canine model. Blood Coagulation & Fibrinolysis. 1(1). 23–30. 3 indexed citations
17.
Dawes, J., et al.. (1988). Release of Highly-Sulphated Glycosaminoglycans and Histamine from Human Basophils. International Archives of Allergy and Immunology. 86(3). 261–266. 7 indexed citations
18.
MacGregor, Ian & William R. Miller. (1988). Urokinase and tissue-type plasminogen activators are present in breast cyst fluids. European Journal of Cancer and Clinical Oncology. 24(6). 985–989. 2 indexed citations
20.
Lane, Peter A., Ian MacGregor, Radosław Michalski, & V V Kakkar. (1977). Studies on Fractionated Heparin. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026